Navigation Links
Archimedes Pharma Receives CHMP Positive Opinion for PecFent(R) for the Treatment of Breakthrough Cancer Pain
Date:6/25/2010

READING, England, June 25, 2010 /PRNewswire/ -- Archimedes Pharma ("Archimedes"), a leading specialty pharma company, today announced that its lead product, PecFent*, has received a Positive Opinion from the Committee for Human Medicinal Products (CHMP), of the European Medicines Agency (EMA). The CHMP is recommending PecFent, an innovative fentanyl nasal spray, be authorised for marketing in European Union countries for the treatment of breakthrough cancer pain (BTCP) - sudden, unpredictable episodes of intense pain that occur despite background pain medication.

Jeffrey H. Buchalter, President and Chief Executive Officer of Archimedes Pharma, commented: "This is a defining moment for Archimedes Pharma. Breakthrough cancer pain is a poorly served indication and affects up to 95% of all cancer patients with pain. Today's announcement by the CHMP is an important step towards bringing a new treatment option to these patients in Europe. It also marks a step change in scale for Archimedes Pharma's already successful European commercial operations and an important landmark in our development as a leading global specialty pharma company. Our clinical development programme delivered excellent results and we look forward to delivering this new option for patients in Europe as soon as we can following the grant of the Marketing Authorisation."

PecFent is an aqueous fentanyl citrate solution using Archimedes Pharma's proprietary PecSys(TM) technology to allow fentanyl to be retained on the nasal mucosa and is designed to produce rapid but controlled absorption into systemic circulation. The positive opinion is based on the results of Archimedes Pharma's comprehensive clinical development programme for
'/>"/>

SOURCE Archimedes Pharma
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6

Related medicine technology :

1. Archimedes Pharma Announces Successful Proof-of-Concept Results on Two Intranasal Development Projects
2. Thomson Scientific Publishes The Ones to Watch - A Quarterly Review of Phase Changes in the Pharmaceutical Pipeline
3. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
4. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
5. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
6. Clinical Trial Effectiveness: How Pharmas & Biotechs Save Cost with Savvy Investigator Management
7. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
8. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
9. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
10. Par Pharmaceutical Begins Shipment of Additional Dosage Strength of Generic TOPROL-XL(R)
11. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/17/2013)... June 17, 2013 Prime Therapeutics, in collaboration with ... Larsen, was awarded the Silver Anvil for its internal communication ... award was presented at the Public Relations Society of America ... 13 at the AXA Equitable Center in ... Anvil, which has been presented annually since 1946, is the ...
(Date:6/17/2013)... little known drug industry tactic to keep generic prescriptions from ... – and a ruling from the highest court in the ... better time for New Yorkers.  AARP says ... all too apparent in New York State.  According to a ... in a near Rx state of crisis, with the majority ...
(Date:6/17/2013)... Franciscan St. Francis Health Cancer Center ... Indiana to use a new drug to ... called Xofigo ®, a radiopharmaceutical used in patients with ... recently was approved for use by the U.S. Food and ... stages it may become castration-resistant, which has become resistant to ...
Breaking Medicine Technology:Prime Therapeutics receives prestigious Silver Anvil Award from Public Relations Society of America 2Supreme Court Ruling on Rx Industry's Pay-to-Delay-Generics Good News for NY Consumers 2Supreme Court Ruling on Rx Industry's Pay-to-Delay-Generics Good News for NY Consumers 3New drug proving effective in attacking advanced prostate cancer 2
... 25 Mayo Clinic,researchers have found what may ... complications of diabetes -- delayed gastric emptying or,gastroparesis. ... red blood,cell derivative increases production of a key ... the current online issue of the,journal Gastroenterology ( ...
... N.J., Sept. 25 Data from a 52-week ... NVO ) liraglutide, a once-daily,human GLP-1 analog, ... study,showed that liraglutide, when taken alone, produces statistically,significant ... patients,with early type 2 diabetes, as compared with ...
Cached Medicine Technology:Mayo Clinic Discovery May Help Diabetic Gastric Problem 2Data from One-Year Liraglutide Phase 3 Study Published Online in The Lancet 2Data from One-Year Liraglutide Phase 3 Study Published Online in The Lancet 3
(Date:6/18/2013)... mapped the signaling network between two previously unconnected proteins, ... cancer cell growth at its starting point. , A ... MD Anderson Cancer Center reported the tie between epidermal ... and MCM7, a protein vital to the first step ... Cancer Cell . , "MCM7 overexpression marks cell proliferation ...
(Date:6/18/2013)... myCNAjobs announces the addition of new ... and tips to the Caregiver Resources Center. , As ... 10,000+ retiring baby boomers each day, the need for ... resources has never been greater. myCNAjobs, the ... recently launched the first-ever free resource center for caregivers ...
(Date:6/18/2013)... Today, Zane Benefits, Inc. published new information ... Benefits, which provides comprehensive and flexible alternatives to traditional ... defined contribution and health reimbursement arrangement ... a company who sets up and implements a Health ... Reimbursement Accounts work. Educating employees about the benefits of ...
(Date:6/18/2013)... June 19, 2013 By studying one of ... outlined a set of successful strategies in his article ... Pages: A Case Study. , The inspirational brand Gollan ... he checked, had an impressive 62 million followers (and rising). ... Facebook’s 25 Top Facebook Pages earlier this year. The Facebook ...
(Date:6/18/2013)... University Hospitals Case Medical Center enrolled their first patients ... evaluating a novel, less-invasive procedure to help clear blockages ... year, more than 300,000 people in the United States ... artery. If left untreated, these blockages can slow or ... potentially disabling stroke, also known as a "brain attack." ...
Breaking Medicine News(10 mins):Health News:Scientists catch EGFR passing a crucial message to cancer-promoting protein 2Health News:myCNAjobs Adds New Resources to Growing Caregiver Career Center 2Health News:Zane Benefits Publishes New Information on Health Reimbursement Accounts 2Health News:Casey Gollan Shows What We Can Learn From One of the Best Facebook Pages There Is 2Health News:Casey Gollan Shows What We Can Learn From One of the Best Facebook Pages There Is 3Health News:UH Case Medical Center among first to enroll patients for global carotid artery trial 2
... depends on not just the particular strain of a pathogen, ... its host, according to new research results. Scientists from ... Agriculture,s Agricultural Research Service (USDA ARS) published the results today ... demonstrates that the pattern of gene regulation--how a cell determines ...
... recommendations to ensure that Medicare beneficiaries have access to ... College of Physicians (ACP). The new policy paper, ... released at Internal Medicine 2012, ACP,s annual scientific meeting. ... advantages and disadvantages of proposals to reform Medicare in ...
... News) -- American children are being exposed to background ... finds. For the study, researchers surveyed over ... 8 months to 8 years old. After taking other ... race, age and family income, the researchers also found ...
... By Serena Gordon HealthDay Reporter , FRIDAY, April ... juvenile open-angle glaucoma, A.J. Esguerra said he,s tried not to let ... not the end of the world," said Esguerra, now 23 and ... activities, and I look at it as just one other thing ...
... mysterious, difficult-to-diagnose, and potentially deadly disease that was ... if treatment is started within the first month ... by researchers from the Perelman School of Medicine ... 565 cases of this recently discovered paraneoplastic condition, ...
... of more effective cancer drugs could be a step ... Medical School, of how an inbuilt ,security check, operates ... chromosomes. , Most cells in our bodies contain ... identities. The process of chromosome segregation is monitored by ...
Cached Medicine News:Health News:History is key factor in plant disease virulence 2Health News:History is key factor in plant disease virulence 3Health News:Internal medicine physician specialists release policy paper on reforming Medicaid 2Health News:Internal medicine physician specialists release policy paper on reforming Medicaid 3Health News:Internal medicine physician specialists release policy paper on reforming Medicaid 4Health News:U.S. Children Exposed to Hours of Background TV Daily 2Health News:For Some, Glaucoma Strikes at a Young Age 2Health News:Early treatment improves outcomes in rare, often undiagnosed form of encephalitis 2Health News:Warwick scientists uncover how 'checkpoint' proteins bind chromosomes 2
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: